17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation

Oncogene

Volumn 12, Issue 4, 1996, Pages 753-763

  Bonapace, Ian M ^a   Addeo, Raffaele ^a   Altucci, Lucia ^a   Cicatiello, Luigi ^a   Bifulco, Maurizio ^b,c   Laezza, Chiara ^b   Salzano, Salvatore ^b   Sica, Vincenzo ^a   Bresciani, Francesco ^a   Weisz, Alessandro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

c fos; Cell cycle; Estrogen; HMG CoA reductase; Mevalonate; ras

Indexed keywords

DIMETHYL SULFATE; ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; SIMVASTATIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA FOOTPRINTING; ENZYME INDUCTION; GENE ACTIVATION; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTO ONCOGENE; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE; CELL LINE; CELL NUCLEUS; CHOLESTEROL; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; FEMALE; G1 PHASE; GENES, FOS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, ESTRADIOL; SIMVASTATIN; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0029670707     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Abbondanza C, de Falco A, Nigro V, Armetta I, Medici N, Moncharmont B, Molinari AM and Puca GA. (1993). Steroids, 58, 4-12.
2. Ambrosino C, Cicatiello L, Cobellis G, Addeo R, Sica V, Bresciani F and Weisz A. (1993). Mol. Endocrinology, 7, 1472-1483.
3. Aronica SM, Kraus WL and Katzenellenbogen BS. (1994). Proc. Natl. Acad. Sci. USA, 91, 8517-8521.
4. Barbu V and Dautry F. (1990). Oncogene, 5, 1077-1080.
5. Beato M. (1989). Cell, 56, 335-344.
6. Boguski MS and McCormick F. (1993). Nature, 366, 643-654.
7. Briand P and Lykksfeldt AE. (1986). Anticancer Res., 6, 85-90.
8. Brunner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M and Lippman ME. (1989). Cancer Res., 49, 1515-1520.
9. Casey PL, Solski PA, Der CJ and Buss JE. (1989). Proc. Natl. Acad. Sci. USA, 86, 8323-8327.
10. Chiba H, Muramatsu M, Nomoto A and Kato H. (1994). Nucleic Acids Res., 22, 1815-1820.
11. Cicatiello L, Sica V, Bresciani F and Weisz A. (1993). Receptor, 3, 17-30.
12. Crespo P, Xu N, Simonds WF and Gutkind JS. (1994). Nature, 369, 418-420.
13. Crews CM, Alessandrini A and Erikson RL. (1992). Cell Growth Diff., 3, 135-142.
14. Curran T, Peters G, van Beveran C, Teich NM and Verma IM. (1982). J. Virol., 44, 674-682.
15. Davidson NE and Lippman ME. (1989). CRC Rev. Oncogenesis, 1, 89-111.
16. DeClue JE, Vass WC, Papageorge AG, Lowry DR and Willumsen BM. (1991). Cancer Res. 51, 712-717.
17. Dey A, Nebert DW and Ozato K. (1991). DNA Cell Biol., 10, 537-544.
18. Doyle A, Griffiths JB and Newell DG. (1994). Cell and Tissue Culture: Laboratory Procedures, Chichester: John Wiley and Sons.
19. Dubik D and Shiu RPC. (1992). Oncogene, 7, 1587-1594.
20. Gibbs JB, Oliff A and Kohl NE. (1994). Cell, 77, 175-178.
21. Grieco D, Beg ZH, Romano A, Bifulco M and Aloj SM. (1990). J. Biol. Chem., 265, 19343-19350.
22. Herrera RE, Shaw PE and Nordheim A. (1989). Nature, 340, 68-70.
23. Hyder SM, Stancel GM, Nawaz Z, McDonnell DP and Loose-Mitchell DS. (1992). J. Biol. Chem., 267, 18047-18054.
24. Iacobelli S, Scambia G, Natoli V, Natoli C and Sica G. (1984). Steroid Biochem., 20, 747-752.
25. Inglese J, Koch WJ, Touhara K and Lefkowitz RJ. (1995). Trends Biochem. Sci., 20, 151-156.
26. Jakóbisiak M, Bruno S, Skierski JS and Darzynkiewicz Z. (1991). Proc. Natl. Acad. Sci. USA, 88, 3628-3632.
27. Keyomarsi K, Sandoval L, Band V and Pardee AB. (1991). Cancer Res. 51, 3602-3609.
28. Knowler JT and Beaumont JM. (1985). Essays Biochem., 20, 1-39.
29. Konig H. (1991). Nucleic acids Res., 19, 3607-3611.
30. Kumar V and Chambon P. (1988). Cell, 55, 145-156.
31. Larsson O, Barrios C, Latham C, Ruiz J, Zetterberger A, Zickert P and Wejde J. (1989). Cancer Res., 49, 5605-5610.
32. Lippman ME, Bolan G and Huff K. (1976). Cancer Res., 36, 4595-4601.
33. Marshall E. (1994). Science, 264, 1524-1527.
34. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A and Chambon P. (1982). Nucleic Acids Res., 10, 7895-7903.
35. Matsuda S, Kadowaki Y, Inchino M, Akiyama T, Toyoshima K and Yamamoto T. (1993). Proc. Natl. Acad. Sci. USA, 90, 10803-10807.
36. Maxam A and Gilbert W. (1980). Methods Enzymol., 65, 499-560.
37. Muchardt C and Yaniv M. (1993). EMBO J., 12, 4279-4290.
38. Müller R, Mumberg D and Lucibello FC. (1993). Biochim. Biophys. Acta., 1155, 151-179.
39. Nemere I, Zhou L-X and Norman AW. (1993). Receptor, 3, 277-291.
40. Nishida E and Gotch Y. (1993). Trends Biochem. Sci., 18, 128-131.
41. Ogasawara M and Sirbasku DA. (1988). In vitro Cell. Dev. Biol., 24, 911-920.
42. Perillo B, Tedesco I, Laezza C, Santillo M, Romano A, Aloj SM and Bifulco M. (1995). J. Biol. Chem., 270, 15237-15241.
43. Peterson CL and Tamkun JW. (1995). Trends Biochem. Sci., 20, 143-146.
44. Pfeifer GP, Steigerwald S, Mueller PR and Riggs AD. (1989). Science, 246, 810-813.
45. Richard-Foy H. (1994). Nature, 370, 417-418.
46. Schmidt RA, Schneider CJ and Glomset JA. (1984). J. Biol. Chem., 259, 10175-10180.
47. Schulz S, Klann RC, Schonfeld S and Nyce JW. (1992). Cancer Res., 52, 1372-1376.
48. Seger R and Krebs EG. (1995). FESEB J. I., 9, 726-735.
49. Seyler-Tuyns A and Birnstiel ML. (1981). J. Mol. Biol., 151, 607-625.
50. Shafie SM. (1980). Science, 209, 701-702.
51. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC. (1990). Cancer Res., 50, 6075-6086.
52. Tait L, Soule HD and Russo J. (1990). Cancer Res., 50, 6087-6094.
53. Tamanoi F. (1993). Trends Biochem. Sci., 18, 349-353.
54. Thomas G. (1992). Cell, 68, 3-6.
55. Truss M, Bartsch J, Schelbert A, Haché RJG and Beato M. (1995). EMBO J., 14, 1737-1751.
56. van der Burg B, van Selm-Miltenburg AJP, de Laat SW and van Zoelen EJ. (1989). Mol. Cell. Endocrinol., 64, 223-228.
57. Vincent TS, Wulfert E and Merler E. (1991). Biochem. Biophys. Res. Comm., 180, 1284-1289.
58. Weigel RJ and de Coninck EC. (1993). Cancer Res., 53, 3472-3474.
59. Weisz A and Bresciani F. (1988). Mol. Endocrinol., 2, 816-824.
60. Weisz A and Bresciani F. (1993). CRC Rev. Oncogenesis, 4, 361-388.
61. Weisz A, Cicatiello L, Persico E, Scalona M and Bresciani F. (1990). Mol. Endrocrinol., 4, 1041-1050.
62. Weisz A, Cicatiello L, Rosales R and Bresciani F. (1991). Horizons in Endocrinology Vol. 2, Maggi M, Greenen V (eds) Raven Press: New York, pp. 115-120.
63. Weisz A and Rosales R. (1990). Nucleic Acids Res., 18, 5097-5106.
64. Wejde J, Calberg M, Hjertman M and Larsson O. (1993). J. Cell. Physiol., 155, 539-548.
65. Zhu AW, Zhao Y, Moller DE and Flier JS. (1994). Mol. Cell. Biol., 14, 8202-8211.